Ireland Inhalers Market to be dominated by Generic Drugs Type through 2028
Rising
prevalence of chronic diseases such as asthma is expected to drive the demand
for the Ireland inhalers market in the forecast period, 2024-2028.
According to TechSci Research report, “Ireland
Inhalers Market - By Region, Competition, Forecast and Opportunities, 2028”,
the Ireland inhalers market is expected to grow at an impressive rate during
the forecast period, 2018-2028. This is due to the rising incidence of asthma
cases, increasing number of pollutants across environment, increase in number
of clinical trials for inhaler’s commercialization in the market, and government
initiatives and policies, etc.
Additionally, technological advancements in the
field of chronic obstructive pulmonary disease (COPD) management, such as
improved inhaler devices, portable spirometers for monitoring lung function,
and digital health solutions, can boost the Ireland inhalers market. For
instance, in April 2020, the two market players announced a strategic
partnership for the development of hardware and software for respiratory
devices. This partnership was expected to treat asthma and COPD management by
offering sensors created to provide the physiological data necessary to
facilitate patient monitoring by the physicians. Moreover, collaborations and
partnerships between healthcare providers, pharmaceutical companies, and
research institutions can foster the development of innovative lung infection
treatments and promote their availability in the market. These collaborations
can propel the growth of Ireland Inhalers market. Inhaler treatments have shown
positive outcomes in managing respiratory conditions, improving symptoms, and
enhancing the overall quality of life for patients. As individuals experience
the benefits of inhaler therapies, there is an increasing acceptance and demand
for these treatments, contributing to the growth of Ireland inhalers market.
However, one of the most restraining factors of the
Ireland inhalers market is high cost of medications and alternative treatment
approaches. The inhaler treatments are considered the standard of care for many
respiratory conditions, alternative treatment approaches, such as oral
medications or nebulizer therapies, may be preferred by some patients. This
preference could be due to personal reasons, convenience, or perceived
effectiveness. The availability and promotion of alternative treatment may
impact the market share of inhalers in Ireland, affecting the growth of Ireland
inhalers market.
Browse
over XX Market Data Figures spread through XX Pages and an in-depth TOC on "Ireland Inhalers Market.”
The Ireland inhalers market is segmented is
segmented by product, technology, disease indication, regional distribution,
and competitional landscape.
Based on product, the market is further bifurcated
into dry powder inhalers, metered dose inhalers, and nebulizers. Metered dose
inhalers segment has dominated the market in 2022. This is ascribed due efficient
and easy to use in a short burst of sprays of a fixed dose which is typically
administered by the patient themselves through inhalation. These inhalers
consist of canister containing drugs that fits into a boot shaped mouthpiece.
Based on technology, the market is bifurcated into manual
operated inhaler devices, digitally operated inhaler devices. The manual
operated inhaler devices segment has dominated the market in 2022. This is
ascribed to easy and simple process. The digitally operated inhaler devices segment
is expected to grow in the forecast period due to change in lifestyle and lack
of time, people are preferring digital inhaler devices.
Based on disease indication, the market is
bifurcated into asthma, chronic obstructive pulmonary diseases, pulmonary
arterial hypertension, and others. The asthma segment dominated the market in
2022 due to rise in asthma cases across the country, increasing patient pool
will significantly drive the segmental growth during the forthcoming period.
Major companies operating in Ireland inhalers
market include:
- GlaxoSmithKline Ireland
- AstraZeneca Ireland
Limited
- Propeller Health
- Teva Pharmaceuticals
Ireland Limited
- Novartis Ireland Limited
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“Ireland inhalers market is expected to witness
significant growth during the forecast period due to the increasing geriatric
population. An increase in number of asthma attack, lifestyle diseases, and rising
healthcare expenditure is expected to grow the Ireland inhalers market.
Additionally, the technological advancements and rising public awareness
regarding high medications cost, are expected to hamper the growth of Ireland
inhalers market in the next few years” said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based global management consulting firm.
“Ireland Inhalers Market, By Product (Dry Powder
Inhalers, Metered Dose Inhalers, and Nebulizers), By Technology (Manual
Operated Inhaler Devices, Digitally Operated Inhaler Devices), Disease
Indication (Asthma, Chronic Obstructive Pulmonary Diseases, Pulmonary Arterial
Hypertension, and Others), By Region, Competition, Forecast and Opportunities, 2028”, has evaluated the future growth potential of Ireland
inhalers market and provides statistics & information on market size, structure,
and future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Ireland inhalers market.
Contact
Mr. Ken
Mathews
708 Third
Avenue,
Manhattan, NY,
New York –
10017
Tel:
+1-646-360-1656
Email:
[email protected]
Website: https://www.techsciresearch.com